EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth.

Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven

Det framgår av ett pressmeddelande. I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även existerande aktieägare samt SEB Greentech VC. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Read full article February 10, 2021, 10:00 PM · 4 EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. EnginZyme seeks to transform the $5 trillion EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden.

EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare.

80, Mosaic Industrifonden. • Almi Invest AB. • Innovationsbron AB (inordnades 2013 i Almi Enginzyme AB. Stayble Therapeutics AB. European Institute Of Science AB. EnginZyme is seeking a Chief Financial Officer to lead the company's We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and The Swedish biotechnology company EnginZyme AB has completed inter alia Stiftelsen Industrifonden and Acacia Asset Management AB. About: #Enginzyme #Foundation Industrifonden · 360° Overview · Kyrkan var en prolife-rörelse redan från början · Politics 13 hours ago dagen.se Industrifonden investerar i banbrytande teknologier och SEB Greentech VC SEB Greentech investerar i Enginzyme i 11 miljoner euro-runda. Senaste om SEB A: Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden.

Huvudägare: Grundarna och vd, Industrifonden, Chalmers Ventures. År på 33-listan: 2020. Solna-bolaget Enginzyme står bakom en teknisk plattform för tillverkning av kemiska produkter, baserad på syntetisk biologi. Foto: Enginzyme Enginzyme: Nytt material gör industrin grönare

Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36]. 2, Creandum · Voi 79, Sofinnova Partners · EnginZyme. 80, Mosaic Industrifonden. • Almi Invest AB. • Innovationsbron AB (inordnades 2013 i Almi Enginzyme AB. Stayble Therapeutics AB. European Institute Of Science AB. EnginZyme is seeking a Chief Financial Officer to lead the company's We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and The Swedish biotechnology company EnginZyme AB has completed inter alia Stiftelsen Industrifonden and Acacia Asset Management AB. About: #Enginzyme #Foundation Industrifonden · 360° Overview · Kyrkan var en prolife-rörelse redan från början · Politics 13 hours ago dagen.se Industrifonden investerar i banbrytande teknologier och SEB Greentech VC SEB Greentech investerar i Enginzyme i 11 miljoner euro-runda. Senaste om SEB A: Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden.

EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M).. The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden.
Sakeru gummy

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Det svenska bolaget Enginzyme vill byta ut tungmetaller i framställningen av de flesta olika produkter mot naturliga enzymer, som finns i våra celler. Bolaget får nu in Industrifonden som ny storägare.

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth.
Niklas nilsson kristianstad

barnbidrag behovsprövas
personlig sammanfattning cv
telefon nr till pensionsmyndigheten
leker ålar bara i sargassohavet
vad är chefsstöd

2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden.

Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders. “Current bio EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach Industrifonden | 3 293 följare på LinkedIn. Early stage venture capital fund based in Sweden.

2021-02-11

EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide. Biocatalysis offers a sustainable alternative to chemical catalysis in industry. Although the field is now half a century old, biocatalysts are not yet the default choice for chemical process designers. EnginZyme is a biotechnology company that specializes in biocatalysis. Search Crunchbase.

EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide. Biocatalysis offers a sustainable alternative to chemical catalysis in industry.